Clinical Trial: Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA
Study Status: Completed
Recruit Status: RECRUITING
Condition: ABPA
Study Type: INTERVENTIONAL
Official Title: Study to Evaluate the Effect of Dose and Duration of Treatment of Itraconazole Administered as a Dry Powder for Inhalation (PUR1900) on Safety, Tolerability, and Potential Outcomes in Adult Patients W
Brief Summary:
The goal of this clinical trial is to learn about PUR1900 as an inhaled, antifungal therapeutic for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in patients with asthma.The main questions it aims to answer are:Is PUR1900 safe and well tolerated in adults with asthma and ABPA?Is there an effect of daily administration of PUR1900 on potential outcome measures in adults with asthma and ABPA?Is there fungal resistance to A. fumigatus?This study includes a 28-day screening period, a 112-day (16-week)…
Read more